KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Operating Leases (2022 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Operating Leases for 2 consecutive years, with $403.7 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Operating Leases changed N/A year-over-year to $403.7 million, compared with a TTM value of $403.7 million through Sep 2023, changed N/A, and an annual FY2022 reading of $413.3 million, changed N/A over the prior year.
  • Operating Leases was $403.7 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $410.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $413.3 million in Q4 2022 and bottomed at $403.7 million in Q3 2023.